Phase II Study of a Non-platinum-containing Doublet of Paclitaxel and Pemetrexed with Bevacizumab (PPB) as Initial Therapy for Patients with Advanced Lung Adenocarcinomas

HYPOTHESIS: Many patients with lung cancers cannot receive platinum-containing regimens due to co-morbid medical conditions. We designed the PPB regimen of paclitaxel, pemetrexed, and bevacizumab to maintain or improve outcomes while averting the unique toxicities of platinum-based chemotherapies. M...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Thorac Oncol
Autori principali: Pietanza, Catherine M., Hellmann, Matthew D., Fiore, John J., Smith-Marrone, Stephanie, Basch, Ethan M., Schwartz, Lawrence H., Ginsberg, Michelle S., Shouery, Marwan, Newman, Samantha K., Shaw, Mary, Rogak, Lauren J., Lash, Alex, Hilden, Patrick, Kris, Mark G.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4877255/
https://ncbi.nlm.nih.gov/pubmed/26964771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtho.2016.02.018
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi